Species | Potential target | Raw | Global | Species |
---|---|---|---|---|
Entamoeba histolytica | hypothetical protein | 0.0058 | 0.0222 | 0.0077 |
Entamoeba histolytica | hypothetical protein | 0.0058 | 0.0222 | 0.0077 |
Trichomonas vaginalis | lipid A export ATP-binding/permease protein msba, putative | 0.005 | 0.0146 | 0.6577 |
Brugia malayi | Sphingomyelin synthase-related 1 | 0.0058 | 0.0222 | 1 |
Echinococcus granulosus | multidrug resistance protein 1 | 0.005 | 0.0146 | 0.6577 |
Loa Loa (eye worm) | ATP-binding cassette sub-family B member 2 | 0.005 | 0.0146 | 0.0649 |
Echinococcus multilocularis | ATP binding cassette sub family B | 0.005 | 0.0141 | 0.6339 |
Trichomonas vaginalis | ATP-binding cassette transporter, putative | 0.005 | 0.0146 | 0.6577 |
Trichomonas vaginalis | lipid A export ATP-binding/permease protein msba, putative | 0.005 | 0.0146 | 0.6577 |
Plasmodium vivax | sphingomyelin synthase 2, putative | 0.0058 | 0.0222 | 1 |
Trichomonas vaginalis | sphingomyelin synthetase, putative | 0.0058 | 0.0222 | 1 |
Trichomonas vaginalis | abcb9, putative | 0.005 | 0.0146 | 0.6577 |
Brugia malayi | Phosphatidylcholine:ceramide cholinephosphotransferase 3 | 0.0058 | 0.0222 | 1 |
Echinococcus multilocularis | multidrug resistance protein 1 | 0.005 | 0.0146 | 0.6577 |
Echinococcus granulosus | 5'partial|ATP binding cassette sub family B | 0.005 | 0.0141 | 0.6339 |
Echinococcus granulosus | ATP binding cassette subfamily B MDR:TAP | 0.005 | 0.0146 | 0.6577 |
Echinococcus multilocularis | ATP binding cassette subfamily B (MDR:TAP) | 0.005 | 0.0146 | 0.6577 |
Loa Loa (eye worm) | hypothetical protein | 0.0058 | 0.0222 | 1 |
Trypanosoma brucei | sphingomyelin/ceramide phosphorylethanolamine synthase, bifunctional | 0.0549 | 0.4967 | 1 |
Onchocerca volvulus | 0.005 | 0.0146 | 0.5 | |
Trichomonas vaginalis | multidrug resistance protein 1, 2, putative | 0.005 | 0.0146 | 0.6577 |
Entamoeba histolytica | hypothetical protein | 0.0058 | 0.0222 | 0.0077 |
Echinococcus multilocularis | ATP binding cassette subfamily B (MDR:TAP) | 0.005 | 0.0146 | 0.6577 |
Loa Loa (eye worm) | hypothetical protein | 0.0058 | 0.0222 | 1 |
Trichomonas vaginalis | lipid A export ATP-binding/permease protein msba, putative | 0.005 | 0.0146 | 0.6577 |
Plasmodium vivax | sphingomyelin synthase 1, putative | 0.0058 | 0.0222 | 1 |
Trichomonas vaginalis | ABC transporter, half transporter, putative | 0.005 | 0.0146 | 0.6577 |
Trichomonas vaginalis | ATP-binding cassette transporter, putative | 0.005 | 0.0146 | 0.6577 |
Plasmodium falciparum | sphingomyelin synthase 2, putative | 0.0058 | 0.0222 | 1 |
Mycobacterium tuberculosis | Probable transmembrane multidrug efflux pump | 0.005 | 0.0146 | 0.5 |
Brugia malayi | Phosphatidylcholine:ceramide cholinephosphotransferase 2 | 0.0058 | 0.0222 | 1 |
Echinococcus multilocularis | multidrug resistance protein 1 | 0.005 | 0.0146 | 0.6577 |
Leishmania major | phosphatidylcholine:ceramide cholinephosphotransferase 2 | 0.0549 | 0.4967 | 1 |
Trichomonas vaginalis | lipid A export ATP-binding/permease protein msba, putative | 0.005 | 0.0146 | 0.6577 |
Loa Loa (eye worm) | multidrug resistance protein 3 | 0.005 | 0.0146 | 0.0649 |
Plasmodium falciparum | sphingomyelin synthase 1, putative | 0.0058 | 0.0222 | 1 |
Trichomonas vaginalis | ATP-binding cassette transporter, putative | 0.005 | 0.0146 | 0.6577 |
Echinococcus granulosus | ATP binding cassette subfamily B MDR:TAP | 0.005 | 0.0146 | 0.6577 |
Loa Loa (eye worm) | hypothetical protein | 0.005 | 0.0146 | 0.0649 |
Echinococcus multilocularis | ATP binding cassette subfamily B (MDR:TAP) | 0.005 | 0.0146 | 0.6577 |
Loa Loa (eye worm) | hypothetical protein | 0.0058 | 0.0222 | 1 |
Trichomonas vaginalis | multidrug resistance protein 1, 2, putative | 0.005 | 0.0146 | 0.6577 |
Trichomonas vaginalis | ABC transporter, putative | 0.005 | 0.0146 | 0.6577 |
Trichomonas vaginalis | sphingomyelin synthetase, putative | 0.0058 | 0.0222 | 1 |
Trypanosoma cruzi | sphingomyelin/ceramide phosphorylethanolamine synthase, bifunctional | 0.0549 | 0.4967 | 0.5 |
Entamoeba histolytica | hypothetical membrane-spanning protein | 0.0058 | 0.0222 | 0.0077 |
Loa Loa (eye worm) | hypothetical protein | 0.0058 | 0.0222 | 1 |
Entamoeba histolytica | hypothetical protein | 0.0058 | 0.0222 | 0.0077 |
Trichomonas vaginalis | lipid A export ATP-binding/permease protein msba, putative | 0.005 | 0.0146 | 0.6577 |
Brugia malayi | Phosphatidylcholine:ceramide cholinephosphotransferase 1 | 0.0058 | 0.0222 | 1 |
Trichomonas vaginalis | sphingomyelin synthetase, putative | 0.0058 | 0.0222 | 1 |
Trichomonas vaginalis | abcb9, putative | 0.005 | 0.0146 | 0.6577 |
Trichomonas vaginalis | taga, putative | 0.005 | 0.0146 | 0.6577 |
Trichomonas vaginalis | ABC transporter, putative | 0.005 | 0.0146 | 0.6577 |
Echinococcus multilocularis | ATP binding cassette subfamily B (MDR:TAP) | 0.005 | 0.0146 | 0.6577 |
Trichomonas vaginalis | ABC transporter, half transporter, putative | 0.005 | 0.0146 | 0.6577 |
Trichomonas vaginalis | lipid A export ATP-binding/permease protein msba, putative | 0.005 | 0.0146 | 0.6577 |
Echinococcus granulosus | ATP binding cassette subfamily B MDR:TAP | 0.005 | 0.0146 | 0.6577 |
Chlamydia trachomatis | ABC transporter ATP binding protein/permease | 0.005 | 0.0146 | 0.5 |
Brugia malayi | Phosphatidylcholine:ceramide cholinephosphotransferase 1 | 0.0058 | 0.0222 | 1 |
Trichomonas vaginalis | sphingomyelin synthetase, putative | 0.0058 | 0.0222 | 1 |
Trichomonas vaginalis | multidrug resistance protein 1, 2, putative | 0.005 | 0.0146 | 0.6577 |
Echinococcus multilocularis | sphingomyelin synthase protein 1 | 0.0058 | 0.0222 | 1 |
Echinococcus granulosus | sphingomyelin synthase protein 1 | 0.0058 | 0.0222 | 1 |
Echinococcus granulosus | multidrug resistance protein 1 | 0.005 | 0.0146 | 0.6577 |
Trichomonas vaginalis | multidrug resistance protein 1, 2, putative | 0.005 | 0.0146 | 0.6577 |
Plasmodium falciparum | sphingomyelin synthase 1, putative | 0.0058 | 0.0222 | 1 |
Echinococcus multilocularis | ATP binding cassette subfamily B (MDR:TAP) | 0.005 | 0.0146 | 0.6577 |
Trichomonas vaginalis | ABC transporter, putative | 0.005 | 0.0146 | 0.6577 |
Echinococcus granulosus | ATP binding cassette subfamily B MDR:TAP | 0.005 | 0.0146 | 0.6577 |
Schistosoma mansoni | spingomyelin synthetase-related | 0.0058 | 0.0222 | 1 |
Loa Loa (eye worm) | hypothetical protein | 0.005 | 0.0146 | 0.0649 |
Trichomonas vaginalis | abcb9, putative | 0.005 | 0.0146 | 0.6577 |
Trichomonas vaginalis | lipid A export ATP-binding/permease protein msba, putative | 0.005 | 0.0146 | 0.6577 |
Loa Loa (eye worm) | hypothetical protein | 0.0058 | 0.0222 | 1 |
Entamoeba histolytica | hypothetical protein | 0.0058 | 0.0222 | 0.0077 |
Trichomonas vaginalis | conserved hypothetical protein | 0.0058 | 0.0222 | 1 |
Trypanosoma brucei | sphingomyelin/ceramide phosphorylethanolamine synthase, bifunctional | 0.0549 | 0.4967 | 1 |
Trichomonas vaginalis | ATP-binding cassette transporter, putative | 0.005 | 0.0146 | 0.6577 |
Toxoplasma gondii | hypothetical protein | 0.0058 | 0.0222 | 1 |
Echinococcus granulosus | multidrug resistance protein 1 | 0.005 | 0.0146 | 0.6577 |
Trichomonas vaginalis | multidrug resistance protein 1, 2, putative | 0.005 | 0.0146 | 0.6577 |
Trichomonas vaginalis | multidrug resistance protein 1, 2, putative | 0.005 | 0.0146 | 0.6577 |
Trichomonas vaginalis | multidrug resistance protein 1, 2, putative | 0.005 | 0.0146 | 0.6577 |
Trichomonas vaginalis | hypothetical protein | 0.0058 | 0.0222 | 1 |
Brugia malayi | Phosphatidylcholine:ceramide cholinephosphotransferase 2 | 0.0058 | 0.0222 | 1 |
Trichomonas vaginalis | ABC transporter, putative | 0.005 | 0.0146 | 0.6577 |
Trichomonas vaginalis | lipid A export ATP-binding/permease protein msba, putative | 0.005 | 0.0146 | 0.6577 |
Trichomonas vaginalis | ATP-binding cassette transporter, putative | 0.005 | 0.0146 | 0.6577 |
Loa Loa (eye worm) | hypothetical protein | 0.0058 | 0.0222 | 1 |
Trypanosoma cruzi | sphingomyelin/ceramide phosphorylethanolamine synthase, bifunctional | 0.0549 | 0.4967 | 0.5 |
Many chemical entities in TDR Targets come from high-throughput screenings with whole cells or tissue samples, and not all assayed compounds have been tested against a single a single target protein, probably because they get ruled out during screening process. Even if these compounds may have not been of interest in the original screening, they may come as interesting leads for other screening assays. Furthermore, we may be able to propose drug-target associations using chemical similarities and network patterns.